Rx High Income Fund

U.S. News evaluated 174 High Yield Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all FolioMetrix funds

See full High Yield Bond rankings

See more fund rankings

Performance

The fund has returned 7.34 percent over the past year.

Trailing Returns Updated 02.28.2014
Year to date 2.5%
1 Year 7.3%
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more FMHIX performance

Summary

The investment seeks to achieve current income and real return. The fund invests in no-load, institutional, and exchange-traded funds that are registered under the Investment Company Act of 1940 and not affiliated with the fund ("portfolio funds") or making direct investments in portfolio securities based upon institutional research, recommendations, and trading signals from investment model managers or other third-party research providers. The investments of the fund and portfolio funds will be comprised of fixed income securities, principally consisting of bonds, corporate debt securities, and government securities.

Fees

Fees are High compared to funds in the same category.
Rx High Income Fund has an expense ratio of 1.76 percent.

See more FMHIX fees

Risk

Risk is N/A compared to funds in the same category according to Morningstar.

See more FMHIX risk